DK3242957T3 - Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme - Google Patents

Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme Download PDF

Info

Publication number
DK3242957T3
DK3242957T3 DK16700202.1T DK16700202T DK3242957T3 DK 3242957 T3 DK3242957 T3 DK 3242957T3 DK 16700202 T DK16700202 T DK 16700202T DK 3242957 T3 DK3242957 T3 DK 3242957T3
Authority
DK
Denmark
Prior art keywords
metabolic
diseases
treat
methods
same
Prior art date
Application number
DK16700202.1T
Other languages
English (en)
Inventor
Vos Willem Meindert De
Thi Phuong Nam Bui
Original Assignee
Univ Wageningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wageningen filed Critical Univ Wageningen
Application granted granted Critical
Publication of DK3242957T3 publication Critical patent/DK3242957T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK16700202.1T 2015-01-09 2016-01-08 Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme DK3242957T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15150701 2015-01-09
PCT/EP2016/050310 WO2016110585A1 (en) 2015-01-09 2016-01-08 Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases

Publications (1)

Publication Number Publication Date
DK3242957T3 true DK3242957T3 (da) 2020-06-02

Family

ID=52434520

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16700202.1T DK3242957T3 (da) 2015-01-09 2016-01-08 Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme

Country Status (13)

Country Link
US (2) US11452746B2 (da)
EP (1) EP3242957B1 (da)
KR (1) KR20170103920A (da)
CN (1) CN107405369A (da)
AU (1) AU2016205975B2 (da)
BR (1) BR112017014649A2 (da)
CA (1) CA2973285C (da)
DK (1) DK3242957T3 (da)
ES (1) ES2796355T3 (da)
PL (1) PL3242957T3 (da)
RU (1) RU2017126666A (da)
SG (1) SG11201705450SA (da)
WO (1) WO2016110585A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3212001A4 (en) 2014-10-31 2018-04-25 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
KR20170103920A (ko) 2015-01-09 2017-09-13 바게닝겐 유니버시테이트 위장관, 대사성 및/또는 기타 질환의 치료 및/또는 예방을 위한 박테리아-함유 조성물 및 이의 사용 방법
EP3419637B1 (en) 2016-02-25 2021-01-27 Caelus Pharmaceuticals B.V. Compositions and methods for preventing and/or treating vitamin b12 deficiency
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
US11850270B2 (en) 2017-12-04 2023-12-26 The BioCollective, LLC Probiotics and methods of use
FR3085963A1 (fr) * 2018-09-19 2020-03-20 Novolyze Composition seche de microorganismes modeles
NL2024569B1 (en) * 2019-12-24 2021-09-06 Univ Wageningen Bacterium comprising myo-inositol to propionate pathway
RU2734718C1 (ru) * 2019-12-31 2020-10-22 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Способ уменьшения выраженности немоторных симптомов у пациентов, страдающих болезнью Паркинсона
NL2028324B1 (en) 2021-05-28 2022-12-12 Caelus Pharmaceuticals B V Insulin-sensitizing agent and butyrate-producing bacterium
WO2023121955A1 (en) * 2021-12-20 2023-06-29 Tainnovation Inc. The methods of and compositions for treating obesity, obesity-related diseases or cancers using a n6-methyllysine/l-lysine mixture

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006070891A1 (ja) * 2004-12-28 2006-07-06 Meiji Seika Kaisha, Ltd. 宿主に対して抗病性を付与する新規な菌株および菌体組成物
RU2613322C2 (ru) 2011-08-30 2017-03-15 Академис Медис Сентрум Способ профилактики и/или лечения инсулинорезистентности
US20140242654A1 (en) 2013-02-26 2014-08-28 Coskata, Inc. Butyrate Producing Clostridium species, Clostridium pharus
US9669059B2 (en) 2013-03-15 2017-06-06 University Of Florida Research Foundation, Incorporated Butyrogenic bacteria as probiotics to treat clostridium difficile
KR20170103920A (ko) 2015-01-09 2017-09-13 바게닝겐 유니버시테이트 위장관, 대사성 및/또는 기타 질환의 치료 및/또는 예방을 위한 박테리아-함유 조성물 및 이의 사용 방법

Also Published As

Publication number Publication date
AU2016205975B2 (en) 2021-05-27
US20180353552A1 (en) 2018-12-13
CA2973285C (en) 2023-10-17
RU2017126666A3 (da) 2019-07-24
BR112017014649A2 (pt) 2018-03-13
SG11201705450SA (en) 2017-07-28
RU2017126666A (ru) 2019-02-12
CN107405369A (zh) 2017-11-28
PL3242957T3 (pl) 2020-10-05
CN107405369A8 (zh) 2018-01-16
EP3242957B1 (en) 2020-03-11
US20210069263A1 (en) 2021-03-11
CA2973285A1 (en) 2016-07-14
US11426436B2 (en) 2022-08-30
US11452746B2 (en) 2022-09-27
WO2016110585A1 (en) 2016-07-14
EP3242957A1 (en) 2017-11-15
KR20170103920A (ko) 2017-09-13
ES2796355T3 (es) 2020-11-26
AU2016205975A1 (en) 2017-07-27

Similar Documents

Publication Publication Date Title
DK3242957T3 (da) Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme
DK3407888T3 (da) Pyridopyrroloquinoxalinforbindelser, deres sammensætninger og anvendelser
DK3207130T3 (da) Sammensætninger af Adenosin Deaminase-2 (ADA2), varianter deraf og fremgangsmåder til anvendelse af samme
DK3116997T3 (da) Crispr/cas-relaterede fremgangsmåder og sammensætninger til behandling af lebers kongenitale amaurose 10 (lca10)
DK3676297T3 (da) Forbindelser, sammensætninger og fremgangsmåder
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3380108T3 (da) Udformede bakterielle sammensætninger
DK3253865T3 (da) Fremgangsmåder til forbedring af virkningen af terapeutiske immunceller
DK3495023T3 (da) Semifluorerede forbindelser og sammensætninger deraf
DK3161124T3 (da) Endofytter, associerede sammensætninger og fremgangsmåder til anvendelse deraf
DK3557998T3 (da) Sammensætninger, kompositioner og anvendelsesmetoder
DK3155101T3 (da) Sammensætninger og fremgangsmåder til ekspression af CRISPR-leder-RNA´er under anvendelse af H1-promotoren
DK3143134T3 (da) Modificerede, naturlige dræberceller og anvendelser deraf
DK3134130T3 (da) Sammensætninger og fremgangsmåder til behandling af hæmoglobinopatier
BR112016018521A2 (pt) composição, e, kit.
DK3297637T3 (da) Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf
KR20180084891A (ko) 구조 조성물 및 방법
DK3204386T3 (da) Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed
DK3316909T3 (da) Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder
DK3580561T3 (da) Hla-baserede metoder, sammensætninger og anvendelse heraf
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
DK3262008T3 (da) Partikelformede sammensætninger til dannelse af geopolymerer, deres anvendelse og fremgangsmåder til dannelse af geopolymere dermed
DK3334444T3 (da) Sammensætning af mælkesyrebakterier til anvendelse i behandling af infektioner, der skyldes propionibacterium acnes, og navnlig til acne
DK3172233T3 (da) Anti-cd74-antistoffer, sammensætninger omfattende anti-cd74- antistoffer og fremgangsmåder til anvendelse af anti-cd74-antistoffer
DK3102555T3 (da) Sammensætninger af forbindelser og anvendelser deraf